Skip to content

KV PHARMACEUTICAL CO /DE/

CIK 0000057055

← back to feed
Revenue (TTM)
$19.1M
−15.0% YoY FY Mar 2012
Net Income (TTM)
−$117.5M
+62.3% YoY FY Mar 2012
EPS Diluted (TTM)
—
FY Mar 2012
Gross Margin
88.0%
FY Mar 2012
Operating Margin
-739.8%
FY Mar 2012
Net Margin
-615.2%
FY Mar 2012
Free Cash Flow (TTM)
−$169.4M
FY Mar 2012
Cash
$50.7M
FY Mar 2012
Total Debt
$450.3M
FY Mar 2012
Shares Outstanding
—
FY Mar 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings